TANG CAPITAL MANAGEMENT LLC Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$481.7B
Holdings
20
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (20 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HRTXHERON THERAPEUTICS INC | 7,907,087 | $84.5B | 17.55% | |
| 2 | RCKTROCKET PHARMACEUTICALS INC | 2,531,800 | $75.7B | 15.71% | |
| 3 | ANABANAPTYSBIO INC | 2,628,678 | $71.3B | 14.80% | |
| 4 | —ODONATE THERAPEUTICS INC | 15,514,566 | $45.1B | 9.37% | |
| 5 | —LA JOLLA PHARMACEUTICAL CO | 10,049,224 | $40.1B | 8.32% | |
| 6 | APVOAPTEVO THERAPEUTICS INC | 1,760,000 | $27.2B | 5.64% | |
| 7 | 5E7ITEOS THERAPEUTICS INC | 900,000 | $24.3B | 5.05% | |
| 8 | CRVSCORVUS PHARMACEUTICALS INC | 3,749,379 | $18.1B | 3.77% | |
| 9 | ALTALTIMMUNE INC | 1,600,000 | $18.1B | 3.76% | |
| 10 | —VINCERX PHARMA INC | 1,030,634 | $16.7B | 3.46% | |
| 11 | CHRSCOHERUS BIOSCIENCES INC | 650,000 | $10.4B | 2.17% | |
| 12 | ATYRATYR PHARMA INC | 1,113,453 | $10.1B | 2.10% | |
| 13 | LPTXEURLEAP THERAPEUTICS INC | 2,500,000 | $10.0B | 2.08% | |
| 14 | CCXIEURCHEMOCENTRYX INC | 500,000 | $8.6B | 1.78% | |
| 15 | TNGXTANGO THERAPEUTICS INC | 468,750 | $6.1B | 1.26% | |
| 16 | —REVIVA PHARMACEUTCLS HLDGS I | 1,200,000 | $4.9B | 1.01% | |
| 17 | EQEQUILLIUM INC | 600,000 | $4.1B | 0.85% | |
| 18 | RLMDRELMADA THERAPEUTICS INC | 100,000 | $2.6B | 0.54% | |
| 19 | NXTCNEXTCURE INC | 300,000 | $2.0B | 0.42% | |
| 20 | —ASLAN PHARMACEUTICALS LTD | 975,305 | $1.7B | 0.36% |